Conference Agenda

OCTER 2012 - Agenda

The ‘4^th Oncology Clinical Trials in Emerging Regions’ (OCTER) conference will assess the current ever changing operational, regulatory and logistical challenges being faced when conducting oncology clinical trials in emerging regions as well as looking at the future role that emerging regions will play and which of the lesser known countries will continue grow in importance.

Some of the subjects under discussion will include –

The role of emerging regions against the backdrop of ever tightening FDA regulations
Small pharma: fighting for attention. Examples of oncology clinical trials being conducted in lesser recognised countries
The CROs role in conducting oncology clinical trials in emerging regions
Randomised trials v Single arm studies in oncology clinical trials
Overall 34% of Phase 3 clinical trials fail – can emerging markets reduce the failure rate or are they contributing towards it?
Overcoming the challenges and variations of localised regulatory procedures
Logistical challenges of conducting clinical trials in emerging regions – what are the main regional challenges and variations
Patient recruitment and retention in emerging countries – challenging the frontiers
Conducting post marketing studies of oncology clinical trials in emerging regions
Oncology clinical trials in China – a case study of large clinical trials and the challenges faced
The role of electronic data capture to accelerate the completion of clinical trials

About Global Engage | T&Cs | Programme | Testimonials | Register

Copyright: Global Engage Ltd. Registered in England. No: 6950636